INFU — InfuSystem Holdings, Inc
—
NYSE ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1337013 ·
Last close
$12.71
Market Cap
$253.15M
52W High
$13.20
52W Low
$7.29
ADV30
124,350
Next earnings
2026-11-03
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 36,933,000 | 21,413,000 | 4,152,000 | 3,231,000 | 97,700,000 | 964,000 | 38,554,000 |
| Mar 2026 | 33,684,000 | 19,682,000 | 1,590,000 | 1,017,000 | 98,657,000 | 2,106,000 | 39,908,000 |
| Dec 2025 | 36,230,000 | 20,435,000 | 3,714,000 | 2,036,000 | 100,560,000 | 3,186,000 | 43,234,000 |
| Sep 2025 | 36,488,000 | 20,820,000 | 3,811,000 | 2,259,000 | 98,881,000 | 955,000 | 43,410,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$23,366,000
Investing CF
$-8,227,000
Financing CF
$-14,895,000
CapEx
$-10,815,000
Dividends Paid
—
Buybacks
$-9,254,000
EPS Diluted TTM
$0.41
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-60,812,000
Inventory
$5,519,000
Receivables
$27,205,000
ST Investments
—
EBIT TTM
$13,312,000
Pretax Income TTM
$12,212,000
Interest Exp TTM
$1,100,000
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$143,335,008
EBITDA
$24,229,000
Free Cash Flow
$10,263,515
Enterprise Value
$265,560,752
Total Cash
$964,000
Total Debt
$24,531,000
Shares Out
19,917,181
Trailing EPS
$0.40
Book Value
$2.97
ROE
15.0%
ROA
7.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 143,436,000 | 11,920,000 | 6,627,000 | 100,560,000 | 43,234,000 | 57,326,000 | 24,408,000 |
| Dec 2024 | 134,861,000 | 6,891,000 | 2,345,000 | 103,614,000 | 46,085,000 | 57,529,000 | 20,459,000 |
| Dec 2023 | 125,785,000 | 4,088,000 | 872,000 | 102,915,000 | 50,613,000 | 52,302,000 | 11,223,000 |
| Dec 2022 | 109,914,000 | 1,654,000 | 18,000 | 99,388,000 | 51,385,000 | 48,003,000 | 17,517,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.52
Max Pain — expiry 2026-11-20 (volume-derived — Yahoo OI feed degraded)
max pain strike: $7.50 · spot: $12.77 · call volume: 42 · put volume: 2
Expected Move to 2026-11-20:
±$2.15
(16.83%) —
implied range
$10.62 –
$14.92
· ATM straddle on $12.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TLSI | TriSalus Life Sciences, Inc. | $267.23M | $4.34 | — |
| OSUR | ORASURE TECHNOLOGIES INC | $271.05M | $3.93 | — |
| UTMD | UTAH MEDICAL PRODUCTS INC | $236.18M | $74.18 | — |
| ANIK | Anika Therapeutics, Inc. | $272.61M | $20.37 | — |
| ELMD | Electromed, Inc. | $233.25M | $27.88 | — |
News headlines (Yahoo Finance, 1h cache)
InfuSystem to Host Investor Webcast on September 24, 2026
2026-09-17 20:30 · Yahoo
InfuSystem (INFU) Q2 2026 Earnings Call Transcript
2026-08-11 17:31 · Yahoo
InfuSystem Holdings, Inc. Q1 2026 Earnings Call Summary
2026-05-07 20:57 · Yahoo
Unique Payer Network Strengthens InfuSystem (INFU)
2026-09-04 13:53 · Yahoo
InfuSystem Holdings, Inc. Q2 2026 Earnings Call Summary
2026-08-04 22:14 · Yahoo
InfuSystems Holdings Inc (INFU) (Q2 2026) Earnings Call Highlights: Record Revenue and Oncology ...
2026-08-04 21:00 · Yahoo
InfuSystems Holdings, Inc. (INFU) Q2 Earnings and Revenues Surpass Estimates
2026-08-04 11:50 · Yahoo
InfuSystem Announces Financial Results for Second Quarter 2026
2026-08-04 10:30 · Yahoo
InfuSystem to Report Second Quarter 2026 Financial Results on August 4, 2026
2026-07-28 10:30 · Yahoo
Are Investors Undervaluing InfuSystems Holdings (INFU) Right Now?
2026-06-29 13:40 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.